Analyze Diet
Clinical microbiology reviews2025; 38(1); e0014622; doi: 10.1128/cmr.00146-22

Companions in antimicrobial resistance: examining transmission of common antimicrobial-resistant organisms between people and their dogs, cats, and horses.

Abstract: SUMMARYNumerous questions persist regarding the role of companion animals as potential reservoirs of antimicrobial-resistant organisms that can infect humans. While relative antimicrobial usage in companion animals is lower than that in humans, certain antimicrobial-resistant pathogens have comparable colonization rates in companion animals and their human counterparts, which inevitably raises questions regarding potential antimicrobial resistance (AMR) transmission. Furthermore, the close contact between pets and their owners, as well as pets, veterinary professionals, and the veterinary clinic environment, provides ample opportunity for zoonotic transmission of antimicrobial-resistant pathogens. Here we summarize what is known about the transmission of AMR and select antimicrobial-resistant organisms between companion animals (primarily dogs, cats, and horses) and humans. We also describe the global distribution of selected antimicrobial-resistant organisms in companion animals. The impact of interspecies AMR transmission within households and veterinary care settings is critically reviewed and discussed in the context of methicillin-resistant staphylococci, extended-spectrum β-lactamase and carbapenemase-producing bacteria. Key research areas are emphasized within established global action plans on AMR, offering valuable insights for shaping future research and surveillance initiatives.
Publication Date: 2025-01-24 PubMed ID: 39853095PubMed Central: PMC11905369DOI: 10.1128/cmr.00146-22Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article examines the role of pets such as dogs, cats, and horses in transmitting antimicrobial-resistant organisms that might cause infections in humans taking into account factors like close proximity and the shared veterinary clinic environment.

Antimicrobial-Resistant Organisms and Companion Animals

  • The paper tries to answer the persisting question of whether companion animals act as reservoirs of antimicrobial-resistant organisms which could pose threats to human health.
  • Even while the use of antimicrobials in animals is lesser than in humans, certain resistant pathogens show similar colonization rates in both these species. This raises concern in terms of potential antimicrobial resistance (AMR) transmission.

Transmission Opportunities

  • The authors posit that the close physical contact shared between pets and their human caretakers, as well as between pets, veterinary professionals, and veterinary clinic environments, may create ample opportunities for zoonotic transmission of antimicrobial-resistant organisms.

The Research Scope

  • This study presents a summary of the known facts regarding AMR transmission and certain antimicrobial-resistant organisms’ interchange between companion animals and humans.
  • The authors have also considered the global distribution of selected antimicrobial-resistant organisms found in companion animals.

Impact of Interspecies AMR Transmission

  • The study critically reviews the impact of the transmission of AMR between species, especially within households and veterinary clinic environments.
  • Some specific microbes, such as methicillin-resistant staphylococci, extended-spectrum β-lactamase, and carbapenemase-producing bacteria, are also discussed in terms of their transmission and possible impact.

Further Research and Surveillance

  • Finally, the paper identifies key research areas that align with the global action plans on AMR.
  • The study contributes valuable insights that could shape future research efforts and initiatives on AMR surveillance.

Cite This Article

APA
Caddey B, Fisher S, Barkema HW, Nobrega DB. (2025). Companions in antimicrobial resistance: examining transmission of common antimicrobial-resistant organisms between people and their dogs, cats, and horses. Clin Microbiol Rev, 38(1), e0014622. https://doi.org/10.1128/cmr.00146-22

Publication

ISSN: 1098-6618
NlmUniqueID: 8807282
Country: United States
Language: English
Volume: 38
Issue: 1
Pages: e0014622

Researcher Affiliations

Caddey, Benjamin
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
Fisher, Sibina
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
Barkema, Herman W
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
Nobrega, Diego B
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.

MeSH Terms

  • Animals
  • Humans
  • Dogs
  • Cats
  • Pets / microbiology
  • Horses
  • Drug Resistance, Bacterial
  • Anti-Bacterial Agents / pharmacology
  • Zoonoses / transmission
  • Zoonoses / microbiology
  • Bacteria / drug effects
  • Bacteria / isolation & purification
  • Bacterial Infections / transmission
  • Bacterial Infections / veterinary
  • Bacterial Infections / microbiology
  • Bacterial Zoonoses / transmission
  • Bacterial Zoonoses / microbiology

Grant Funding

  • CRC-2022-00168 / Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 257 references
  1. World Health Organization. Global action plan on antimicrobial resistance.. 2015.
    pubmed: 26242647
  2. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.. The Lancet 399:629–655.
  3. Interagency Coordination Group on Antimicrobial Resistance. No time to wait: securing the future from drug-resistant infections. Report to the secretary general of the United Nations.. 2019.
  4. O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations: tackling a crisis for the health and wealth of nations.. 2014.
  5. Pires SM, Duarte AS, Hald T. Source attribution and risk assessment of antimicrobial resistance.. Microbiol Spectr 6.
  6. Duarte ASR, Röder T, Van Gompel L, Petersen TN, Hansen RB, Hansen IM, Bossers A, Aarestrup FM, Wagenaar JA, Hald T. Metagenomics-based approach to source-attribution of antimicrobial resistance determinants - identification of reservoir resistome signatures.. Front Microbiol 11:601407.
    doi: 10.3389/fmicb.2020.601407pmc: PMC7843941pubmed: 33519742google scholar: lookup
  7. Kim DW, Cha CJ. Antibiotic resistome from the one-health perspective: understanding and controlling antimicrobial resistance transmission.. Exp Mol Med 53:301–309.
    doi: 10.1038/s12276-021-00569-zpmc: PMC8080597pubmed: 33642573google scholar: lookup
  8. Day MJ. The CALLISTO project: a summary.. J Comp Pathol 155:S1–7.
    doi: 10.1016/j.jcpa.2015.01.005pubmed: 25728814google scholar: lookup
  9. Wertheim HFL, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections.. Lancet Infect Dis 5:751–762.
    doi: 10.1016/S1473-3099(05)70295-4pubmed: 16310147google scholar: lookup
  10. Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, Holland TL, Fowler VG. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research.. Nat Rev Microbiol 17:203–218.
    doi: 10.1038/s41579-018-0147-4pmc: PMC6939889pubmed: 30737488google scholar: lookup
  11. Kasela M, Ossowski M, Dzikoń E, Ignatiuk K, Wlazło Ł, Malm A. The epidemiology of animal-associated methicillin-resistant Staphylococcus aureus. Antibiotics (Basel) 12:1079.
  12. Scott GM, Thomson R, Malone-Lee J, Ridgway GL. Cross-infection between animals and man: possible feline transmission of Staphylococcus aureus infection in humans?. J Hosp Infect 12:29–34.
    doi: 10.1016/0195-6701(88)90119-3pubmed: 2905371google scholar: lookup
  13. Khairullah AR, Sudjarwo SA, Effendi MH, Ramandinianto SC, Gelolodo MA, Widodo A, Riwu KHP, Kurniawati DA. Pet animals as reservoirs for spreading methicillin-resistant Staphylococcus aureus to human health.. J Adv Vet Anim Res 10:1–13.
    doi: 10.5455/javar.2023.j641pmc: PMC10122942pubmed: 37155545google scholar: lookup
  14. Hackmann C, Gastmeier P, Schwarz S, Lübke-Becker A, Bischoff P, Leistner R. Pet husbandry as a risk factor for colonization or infection with MDR organisms: a systematic meta-analysis.. J Antimicrob Chemother 76:1392–1405.
    doi: 10.1093/jac/dkab058pubmed: 33864082google scholar: lookup
  15. Armand-Lefevre L, Ruimy R, Andremont A. Clonal comparison of Staphylococcus aureus isolates from healthy pig farmers, human controls, and pigs.. Emerg Infect Dis 11:711–714.
    doi: 10.3201/eid1105.040866pmc: PMC3320358pubmed: 15890125google scholar: lookup
  16. Butaye P, Argudín MA, Smith TC. Livestock-associated MRSA and its current evolution.. Curr Clin Micro Rep 3:19–31.
    doi: 10.1007/s40588-016-0031-9google scholar: lookup
  17. Murray CK, Holmes RL, Ellis MW, Mende K, Wolf SE, McDougal LK, Guymon CH, Hospenthal DR. Twenty-five year epidemiology of invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered at a burn center.. Burns 35:1112–1117.
    doi: 10.1016/j.burns.2009.02.013pubmed: 19477601google scholar: lookup
  18. Nübel U, Dordel J, Kurt K, Strommenger B, Westh H, Shukla SK, Zemlicková H, Leblois R, Wirth T, Jombart T, Balloux F, Witte W. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus.. PLoS Pathog 6:e1000855.
  19. Richardson JF, Reith S. Characterization of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods.. J Hosp Infect 25:45–52.
    doi: 10.1016/0195-6701(93)90007-mpubmed: 7901274google scholar: lookup
  20. Cimolai N. Methicillin-resistant Staphylococcus aureus in Canada: a historical perspective and lessons learned.. Can J Microbiol 56:89–120.
    doi: 10.1139/w09-109pubmed: 20237572google scholar: lookup
  21. Humphreys H, Coleman DC. Contribution of whole-genome sequencing to understanding of the epidemiology and control of meticillin-resistant Staphylococcus aureus.. J Hosp Infect 102:189–199.
    doi: 10.1016/j.jhin.2019.01.025pubmed: 30721732google scholar: lookup
  22. Effelsberg N, Stegger M, Peitzmann L, Altinok O, Coombs GW, Pichon B, Kearns A, Randad PR, Heaney CD, Bletz S, Schaumburg F, Mellmann A. Global epidemiology and evolutionary history of Staphylococcus aureus ST45.. J Clin Microbiol 59:e02198-20.
    doi: 10.1128/JCM.02198-20pmc: PMC7771469pubmed: 33087430google scholar: lookup
  23. Kim ES, Lee HJ, Chung G-T, Lee Y-S, Shin D-H, Jung S-I, Song K-H, Park W-B, Kim NJ, Park KU, Kim E-C, Oh M-D, Kim HB. Molecular characterization of methicillin-resistant Staphylococcus aureus isolates in Korea.. J Clin Microbiol 49:1979–1982.
    doi: 10.1128/JCM.00098-11pmc: PMC3122668pubmed: 21411580google scholar: lookup
  24. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA).. Proc Natl Acad Sci U S A 99:7687–7692.
    doi: 10.1073/pnas.122108599pmc: PMC124322pubmed: 12032344google scholar: lookup
  25. Gill JL, Hedge J, Wilson DJ, MacLean RC. Evolutionary processes driving the rise and fall of Staphylococcus aureus ST239, a dominant hybrid pathogen.. MBio 12:e0216821.
    doi: 10.1128/mBio.02168-21pmc: PMC8669471pubmed: 34903061google scholar: lookup
  26. Davis MF, Misic AM, Morris DO, Moss JT, Tolomeo P, Beiting DP, Nachamkin I, Lautenbach E, Rankin SC. Genome sequencing reveals strain dynamics of methicillin-resistant Staphylococcus aureus in the same household in the context of clinical disease in a person and a dog.. Vet Microbiol 180:304–307.
  27. Nienhoff U, Kadlec K, Chaberny IF, Verspohl J, Gerlach GF, Schwarz S, Simon D, Nolte I. Transmission of methicillin-resistant Staphylococcus aureus strains between humans and dogs: two case reports.. J Antimicrob Chemother 64:660–662.
    doi: 10.1093/jac/dkp243pubmed: 19608580google scholar: lookup
  28. Sing A, Tuschak C, Hörmansdorfer S. Methicillin-resistant Staphylococcus aureus in a family and its pet cat.. N Engl J Med 358:1200–1201.
    doi: 10.1056/NEJMc0706805pubmed: 18337614google scholar: lookup
  29. van Duijkeren E, Ten Horn L, Wagenaar JA, de Bruijn M, Laarhoven L, Verstappen K, de Weerd W, Meessen N, Duim B. Suspected horse-to-human transmission of MRSA ST398.. Emerg Infect Dis 17:1137–1139.
    doi: 10.3201/eid/1706.101330pmc: PMC3358200pubmed: 21749795google scholar: lookup
  30. Morris DO, Lautenbach E, Zaoutis T, Leckerman K, Edelstein PH, Rankin SC. Potential for pet animals to harbour methicillin-resistant Staphylococcus aureus when residing with human MRSA patients.. Zoonoses Public Health 59:286–293.
  31. Oh JY, Chae JC, Han JI, Song WK, Lee CM, Park HM. Distribution and epidemiological relatedness of methicillin-resistant Staphylococcus aureus isolated from companion dogs, owners, and environments.. J Vet Med Sci 82:1379–1386.
    doi: 10.1292/jvms.19-0523pmc: PMC7538317pubmed: 32713876google scholar: lookup
  32. Van den Eede A, Martens A, Floré K, Denis O, Gasthuys F, Haesebrouck F, Van den Abeele A, Hermans K. MRSA carriage in the equine community: an investigation of horse-caretaker couples.. Vet Microbiol 163:313–318.
    doi: 10.1016/j.vetmic.2012.12.038pubmed: 23434186google scholar: lookup
  33. Faires MC, Tater KC, Weese JS. An investigation of methicillin-resistant Staphylococcus aureus colonization in people and pets in the same household with an infected person or infected pet.. J Am Vet Med Assoc 235:540–543.
    doi: 10.2460/javma.235.5.540pubmed: 19719444google scholar: lookup
  34. Shankar N, Soe P, Tam CC. Prevalence and risk of acquisition of methicillin-resistant Staphylococcus aureus among households: a systematic review.. Int J Infect Dis 92:105–113.
    doi: 10.1016/j.ijid.2020.01.008pubmed: 31945492google scholar: lookup
  35. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors.. Clin Infect Dis 36:131–139.
    doi: 10.1086/345436pubmed: 12522744google scholar: lookup
  36. Uhlemann A-C, Dordel J, Knox JR, Raven KE, Parkhill J, Holden MTG, Peacock SJ, Lowy FD. Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community.. Proc Natl Acad Sci U S A 111:6738–6743.
    doi: 10.1073/pnas.1401006111pmc: PMC4020051pubmed: 24753569google scholar: lookup
  37. Aires-de-Sousa M. Methicillin-resistant Staphylococcus aureus among animals: current overview.. Clin Microbiol Infect 23:373–380.
    doi: 10.1016/j.cmi.2016.11.002pubmed: 27851997google scholar: lookup
  38. Weese JS, Archambault M, Willey BM, Hearn P, Kreiswirth BN, Said-Salim B, McGeer A, Likhoshvay Y, Prescott JF, Low DE. Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002.. Emerg Infect Dis 11:430–435.
    doi: 10.3201/eid1103.040481pmc: PMC3298236pubmed: 15757559google scholar: lookup
  39. McCarthy AJ, Lindsay JA, Loeffler A. Are all meticillin-resistant Staphylococcus aureus (MRSA) equal in all hosts? Epidemiological and genetic comparison between animal and human MRSA.. Vet Dermatol 23:267–275.
  40. Moodley A, Stegger M, Bagcigil AF, Baptiste KE, Loeffler A, Lloyd DH, Williams NJ, Leonard N, Abbott Y, Skov R, Guardabassi L. Spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland.. J Antimicrob Chemother 58:1118–1123.
    doi: 10.1093/jac/dkl394pubmed: 17030517google scholar: lookup
  41. Worthing KA, Abraham S, Pang S, Coombs GW, Saputra S, Jordan D, Wong HS, Abraham RJ, Trott DJ, Norris JM. Molecular Characterization of methicillin-resistant Staphylococcus aureus Isolated from Australian animals and veterinarians.. Microb Drug Resist 24:203–212.
    doi: 10.1089/mdr.2017.0032pubmed: 28598251google scholar: lookup
  42. Cuny C, Abdelbary MMH, Köck R, Layer F, Scheidemann W, Werner G, Witte W. Methicillin-resistant Staphylococcus aureus from infections in horses in Germany are frequent colonizers of veterinarians but rare among MRSA from infections in humans.. One Health 2:11–17.
  43. Murphy RJT, Ramsay JP, Lee YT, Pang S, O’Dea MA, Pearson JC, Axon JE, Raby E, Abdulgader SM, Whitelaw A, Coombs GW. Multiple introductions of methicillin-resistant Staphylococcus aureus ST612 into Western Australia associated both with human and equine reservoirs.. Int J Antimicrob Agents 54:681–685.
  44. Weese JS. Methicillin-resistant Staphylococcus aureus in animals.. ILAR J 51:233–244.
    doi: 10.1093/ilar.51.3.233pubmed: 21131724google scholar: lookup
  45. Uchida-Fujii E, Niwa H, Kanai K, Kinoshita Y, Kuroda T, Nukada T, Ueno T. Outbreak of methicillin-resistant Staphylococcus aureus sequence type 1, spa type t1784, in an equine hospital in Japan.. Vet Anim Sci 17:100259.
    doi: 10.1016/j.vas.2022.100259pmc: PMC9253831pubmed: 35800153google scholar: lookup
  46. Schwaber MJ, Navon-Venezia S, Masarwa S, Tirosh-Levy S, Adler A, Chmelnitsky I, Carmeli Y, Klement E, Steinman A. Clonal transmission of a rare methicillin-resistant Staphylococcus aureus genotype between horses and staff at a veterinary teaching hospital.. Vet Microbiol 162:907–911.
    doi: 10.1016/j.vetmic.2012.11.020pubmed: 23265243google scholar: lookup
  47. Sieber S, Gerber V, Jandova V, Rossano A, Evison JM, Perreten V. Evolution of multidrug-resistant Staphylococcus aureus infections in horses and colonized personnel in an equine clinic between 2005 and 2010.. Microb Drug Resist 17:471–478.
    doi: 10.1089/mdr.2010.0188pubmed: 21875361google scholar: lookup
  48. Ishihara K, Saito M, Shimokubo N, Muramatsu Y, Maetani S, Tamura Y. Methicillin-resistant Staphylococcus aureus carriage among veterinary staff and dogs in private veterinary clinics in Hokkaido, Japan.. Microbiol Immunol 58:149–154.
    doi: 10.1111/1348-0421.12128pubmed: 24397564google scholar: lookup
  49. Garcia-Graells C, Antoine J, Larsen J, Catry B, Skov R, Denis O. Livestock veterinarians at high risk of acquiring methicillin-resistant Staphylococcus aureus ST398.. Epidemiol Infect 140:383–389.
    doi: 10.1017/S0950268811002263pubmed: 22082716google scholar: lookup
  50. Wulf M, van Nes A, Eikelenboom-Boskamp A, de Vries J, Melchers W, Klaassen C, Voss A. Methicillin-resistant Staphylococcus aureus in veterinary doctors and students, the Netherlands .. Emerg Infect Dis 12:1939–1941.
    doi: 10.3201/eid1212.060355pmc: PMC3291345pubmed: 17326948google scholar: lookup
  51. Sato T, Usui M, Konishi N, Kai A, Matsui H, Hanaki H, Tamura Y. Closely related methicillin-resistant Staphylococcus aureus isolates from retail meat, cows with mastitis, and humans in Japan.. PLoS One 12:e0187319.
  52. Dulon M, Peters C, Schablon A, Nienhaus A. MRSA carriage among healthcare workers in non-outbreak settings in Europe and the United States: a systematic review.. BMC Infect Dis 14:363.
    doi: 10.1186/1471-2334-14-363pmc: PMC4094410pubmed: 24996225google scholar: lookup
  53. Giri S, Ghimire A, Mishra A, Acharya K, Kuikel S, Tiwari A, Mishra SK. Prevalence of methicillin-resistant Staphylococcus aureus carriage among healthcare workers in South Asia in non-outbreak settings: a systematic review and meta-analysis.. Am J Infect Control 51:184–193.
    doi: 10.1016/j.ajic.2022.06.001pubmed: 35697125google scholar: lookup
  54. Vincze S, Brandenburg AG, Espelage W, Stamm I, Wieler LH, Kopp PA, Lübke-Becker A, Walther B. Risk factors for MRSA infection in companion animals: results from a case-control study within Germany.. Int J Med Microbiol 304:787–793.
    doi: 10.1016/j.ijmm.2014.07.007pubmed: 25130703google scholar: lookup
  55. Loeffler A, Pfeiffer DU, Lindsay JA, Soares Magalhães RJ, Lloyd DH. Prevalence of and risk factors for MRSA carriage in companion animals: a survey of dogs, cats and horses.. Epidemiol Infect 139:1019–1028.
    doi: 10.1017/S095026881000227Xpubmed: 20943000google scholar: lookup
  56. Elmoslemany A, Elsohaby I, Alorabi M, Alkafafy M, Al-Marri T, Aldoweriej A, Alaql FA, Almubarak A, Fayez M. Diversity and risk factors associated with multidrug and methicillin-resistant staphylococci isolated from cats admitted to a veterinary clinic in Eastern Province, Saudi Arabia.. Antibiotics (Basel) 10:367.
    doi: 10.3390/antibiotics10040367pmc: PMC8066541pubmed: 33807318google scholar: lookup
  57. Soares Magalhães RJ, Loeffler A, Lindsay J, Rich M, Roberts L, Smith H, Lloyd DH, Pfeiffer DU. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in dogs and cats: a case-control study.. Vet Res 41:55.
    doi: 10.1051/vetres/2010028pmc: PMC2879574pubmed: 20423695google scholar: lookup
  58. Carfora V, Caprioli A, Grossi I, Pepe M, Alba P, Lorenzetti S, Amoruso R, Sorbara L, Franco A, Battisti A. A methicillin-resistant Staphylococcus aureus (MRSA) sequence type 8, spa type t11469 causing infection and colonizing horses in Italy.. Pathog Dis 74:ftw025.
    doi: 10.1093/femspd/ftw025pubmed: 27052029google scholar: lookup
  59. Hoet AE, Johnson A, Nava-Hoet RC, Bateman S, Hillier A, Dyce J, Gebreyes WA, Wittum TE. Environmental methicillin-resistant Staphylococcus aureus in a veterinary teaching hospital during a nonoutbreak period.. Vector Borne Zoonotic Dis 11:609–615.
    doi: 10.1089/vbz.2010.0181pmc: PMC3391706pubmed: 21417926google scholar: lookup
  60. van Balen J, Kelley C, Nava-Hoet RC, Bateman S, Hillier A, Dyce J, Wittum TE, Hoet AE. Presence, distribution, and molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small animal teaching hospital: a year-long active surveillance targeting dogs and their environment.. Vector Borne Zoonotic Dis 13:299–311.
    doi: 10.1089/vbz.2012.1142pmc: PMC3636584pubmed: 23473216google scholar: lookup
  61. Dalton KR, Rock C, Carroll KC, Davis MF. One Health in hospitals: how understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections.. Antimicrob Resist Infect Control 9:78.
    doi: 10.1186/s13756-020-00737-2pmc: PMC7268532pubmed: 32487220google scholar: lookup
  62. Moses IB, Santos FF, Gales AC. Human colonization and infection by Staphylococcus pseudintermedius: an emerging and underestimated zoonotic pathogen.. Microorganisms 11:581.
  63. Moodley A, Damborg P, Nielsen SS. Antimicrobial resistance in methicillin susceptible and methicillin resistant Staphylococcus pseudintermedius of canine origin: literature review from 1980 to 2013.. Vet Microbiol 171:337–341.
    doi: 10.1016/j.vetmic.2014.02.008pubmed: 24613081google scholar: lookup
  64. Somayaji R, Rubin JE, Priyantha MAR, Church D. Exploring Staphylococcus pseudintermedius: an emerging zoonotic pathogen?. Future Microbiol 11:1371–1374.
    doi: 10.2217/fmb-2016-0137pubmed: 27750440google scholar: lookup
  65. Gortel K, Campbell KL, Kakoma I, Whittem T, Schaeffer DJ, Weisiger RM. Methicillin resistance among staphylococci isolated from dogs.. Am J Vet Res 60:1526–1530.
    pubmed: 10622162
  66. Phumthanakorn N, Fungwithaya P, Chanchaithong P, Prapasarakul N. Enterotoxin gene profile of methicillin-resistant Staphylococcus pseudintermedius isolates from dogs, humans and the environment.. J Med Microbiol 67:866–873.
    doi: 10.1099/jmm.0.000748pubmed: 29724270google scholar: lookup
  67. Ishihara K, Shimokubo N, Sakagami A, Ueno H, Muramatsu Y, Kadosawa T, Yanagisawa C, Hanaki H, Nakajima C, Suzuki Y, Tamura Y. Occurrence and molecular characteristics of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius in an academic veterinary hospital.. Appl Environ Microbiol 76:5165–5174.
    doi: 10.1128/AEM.02780-09pmc: PMC2916498pubmed: 20543040google scholar: lookup
  68. Viegas FM, Santana JA, Silva BA, Xavier RGC, Bonisson CT, Câmara JLS, Rennó MC, Cunha JLR, Figueiredo HCP, Lobato FCF, Silva ROS. Occurrence and characterization of methicillin-resistant Staphylococcus spp. in diseased dogs in Brazil.. PLoS One 17:e0269422.
  69. Kitagawa H, Hisatsune J, Ohge H, Kutsuno S, Hara T, Masuda K, Aziz F, Sugai M. Implanted Port Catheter system infection caused by methicillin-resistant Staphylococcus pseudintermedius ST71-SCCmec type III.. Intern Med 60:2337–2340.
  70. Stegmann R, Burnens A, Maranta CA, Perreten V. Human infection associated with methicillin-resistant Staphylococcus pseudintermedius ST71.. J Antimicrob Chemother 65:2047–2048.
    doi: 10.1093/jac/dkq241pubmed: 20601356google scholar: lookup
  71. Youn JH, Moodley A, Park YH, Sugimoto C. Genome sequence of methicillin-resistant Staphylococcus pseudintermedius sequence type 233 (ST233) strain K7, of human origin.. Genome Announc 1:e00310-13.
    doi: 10.1128/genomeA.00310-13pmc: PMC3707588pubmed: 23788539google scholar: lookup
  72. Starlander G, Börjesson S, Grönlund-Andersson U, Tellgren-Roth C, Melhus A. Cluster of infections caused by methicillin-resistant Staphylococcus pseudintermedius in humans in a tertiary hospital.. J Clin Microbiol 52:3118–3120.
    doi: 10.1128/JCM.00703-14pmc: PMC4136194pubmed: 24871217google scholar: lookup
  73. Boost MV, So SYC, Perreten V. Low rate of methicillin-resistant coagulase-positive staphylococcal colonization of veterinary personnel in Hong Kong.. Zoonoses Public Health 58:36–40.
  74. Adiguzel MC, Schaefer K, Rodriguez T, Ortiz J, Sahin O. Prevalence, mechanism, genetic diversity, and cross-resistance patterns of methicillin-resistant Staphylococcus isolated from companion animal clinical samples submitted to a veterinary diagnostic laboratory in the Midwestern United States.. Antibiotics (Basel) 11:609.
    doi: 10.3390/antibiotics11050609pmc: PMC9138002pubmed: 35625253google scholar: lookup
  75. Perreten V, Kadlec K, Schwarz S, Gronlund Andersson U, Finn M, Greko C, Moodley A, Kania SA, Frank LA, Bemis DA, Franco A, Iurescia M, Battisti A, Duim B, Wagenaar JA, van Duijkeren E, Weese JS, Fitzgerald JR, Rossano A, Guardabassi L. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study.. J Antimicrob Chemother 65:1145–1154.
    doi: 10.1093/jac/dkq078pubmed: 20348087google scholar: lookup
  76. Feng Y, Tian W, Lin D, Luo Q, Zhou Y, Yang T, Deng Y, Liu YH, Liu JH. Prevalence and characterization of methicillin-resistant Staphylococcus pseudintermedius in pets from South China.. Vet Microbiol 160:517–524.
    doi: 10.1016/j.vetmic.2012.06.015pubmed: 22770517google scholar: lookup
  77. Damborg P, Moodley A, Aalbæk B, Ventrella G, Dos Santos TP, Guardabassi L. High genotypic diversity among methicillin-resistant Staphylococcus pseudintermedius isolated from canine infections in Denmark.. BMC Vet Res 12:131.
    doi: 10.1186/s12917-016-0756-ypmc: PMC4928297pubmed: 27357502google scholar: lookup
  78. Ventrella G, Moodley A, Grandolfo E, Parisi A, Corrente M, Buonavoglia D, Guardabassi L. Frequency, antimicrobial susceptibility and clonal distribution of methicillin-resistant Staphylococcus pseudintermedius in canine clinical samples submitted to a veterinary diagnostic laboratory in Italy: a 3-year retrospective investigation.. Vet Microbiol 211:103–106.
    doi: 10.1016/j.vetmic.2017.09.015pubmed: 29102103google scholar: lookup
  79. Kang JH, Chung TH, Hwang CY. Clonal distribution of methicillin-resistant Staphylococcus pseudintermedius isolates from skin infection of dogs in Korea.. Vet Microbiol 210:32–37.
    doi: 10.1016/j.vetmic.2017.08.017pubmed: 29103693google scholar: lookup
  80. Han JI, Rhim H, Yang CH, Park HM. Molecular characteristics of new clonal complexes of Staphylococcus pseudintermedius from clinically normal dogs.. Vet Quater 38:14–20.
  81. Gagetti P, Wattam AR, Giacoboni G, De Paulis A, Bertona E, Corso A, Rosato AE. Identification and molecular epidemiology of methicillin resistant Staphylococcus pseudintermedius strains isolated from canine clinical samples in Argentina.. BMC Vet Res 15:264.
    doi: 10.1186/s12917-019-1990-xpmc: PMC6660709pubmed: 31351494google scholar: lookup
  82. Menandro ML, Dotto G, Mondin A, Martini M, Ceglie L, Pasotto D. Prevalence and characterization of methicillin-resistant Staphylococcus pseudintermedius from symptomatic companion animals in Northern Italy: clonal diversity and novel sequence types.. Comp Immunol Microbiol Infect Dis 66:101331.
    doi: 10.1016/j.cimid.2019.101331pubmed: 31437680google scholar: lookup
  83. Lee GY, Yang SJ. Comparative assessment of genotypic and phenotypic correlates of Staphylococcus pseudintermedius strains isolated from dogs with otitis externa and healthy dogs.. Comp Immunol Microbiol Infect Dis 70:101376.
    doi: 10.1016/j.cimid.2019.101376pubmed: 31703937google scholar: lookup
  84. Srednik ME, Perea CA, Giacoboni GI, Hicks JA, Schlater LK. First report of Staphylococcus pseudintermedius ST71-SCCmec III and ST45-ΨSCCmec57395 from canine pyoderma in Argentina.. BMC Res Notes 16:19.
    doi: 10.1186/s13104-023-06285-3pmc: PMC9948440pubmed: 36823518google scholar: lookup
  85. Penna B, Silva MB, Botelho AMN, Ferreira FA, Ramundo MS, Silva-Carvalho MC, Rabello RF, Vieira-da-Motta O, Figueiredo AMS. Detection of the international lineage ST71 of methicillin-resistant Staphylococcus pseudintermedius in two cities in Rio de Janeiro State.. Braz J Microbiol 53:2335–2341.
    doi: 10.1007/s42770-022-00852-9pmc: PMC9679067pubmed: 36319942google scholar: lookup
  86. Wegener A, Damborg P, Guardabassi L, Moodley A, Mughini-Gras L, Duim B, Wagenaar JA, Broens EM. Specific staphylococcal cassette chromosome mec (SCCmec) types and clonal complexes are associated with low-level amoxicillin/clavulanic acid and cefalotin resistance in methicillin-resistant Staphylococcus pseudintermedius.. J Antimicrob Chemother 75:508–511.
    doi: 10.1093/jac/dkz509pmc: PMC9297311pubmed: 31846043google scholar: lookup
  87. Laarhoven LM, de Heus P, van Luijn J, Duim B, Wagenaar JA, van Duijkeren E. Longitudinal study on methicillin-resistant Staphylococcus pseudintermedius in households.. PLoS One 6:e27788.
  88. Walther B, Hermes J, Cuny C, Wieler LH, Vincze S, Abou Elnaga Y, Stamm I, Kopp PA, Kohn B, Witte W, Jansen A, Conraths FJ, Semmler T, Eckmanns T, Lübke-Becker A. Sharing more than friendship--nasal colonization with coagulase-positive staphylococci (CPS) and co-habitation aspects of dogs and their owners.. PLoS One 7:e35197.
  89. Gómez-Sanz E, Torres C, Lozano C, Zarazaga M. High diversity of Staphylococcus aureus and Staphylococcus pseudintermedius lineages and toxigenic traits in healthy pet-owning household members. Underestimating normal household contact?. Comp Immunol Microbiol Infect Dis 36:83–94.
    doi: 10.1016/j.cimid.2012.10.001pubmed: 23153600google scholar: lookup
  90. Lozano C, Rezusta A, Ferrer I, Pérez-Laguna V, Zarazaga M, Ruiz-Ripa L, Revillo MJ, Torres C. Staphylococcus pseudintermedius human infection cases in Spain: dog-to-human transmission.. Vector Borne Zoonotic Dis 17:268–270.
    doi: 10.1089/vbz.2016.2048pubmed: 28075235google scholar: lookup
  91. Vincze S, Paasch A, Walther B, Ruscher C, Lübke-Becker A, Wieler LH, Barbara K. Multidrug- and methicillin resistant Staphylococcus pseudintermedius as a cause of canine pyoderma: a case report.. Berl Munch Tierarztl Wochenschr 123:353–358.
    pubmed: 21038805
  92. Kang JH, Hwang CY. One health approach to genetic relatedness in SCCmec between methicillin-resistant Staphylococcus isolates from companion dogs with pyoderma and their owners.. Vet Microbiol 253:108957.
    doi: 10.1016/j.vetmic.2020.108957pubmed: 33385887google scholar: lookup
  93. Kjellman EE, Slettemeås JS, Small H, Sunde M. Methicillin-resistant Staphylococcus pseudintermedius (MRSP) from healthy dogs in Norway - occurrence, genotypes and comparison to clinical MRSP.. Microbiologyopen 4:857–866.
    doi: 10.1002/mbo3.258pmc: PMC4694142pubmed: 26423808google scholar: lookup
  94. Beck KM, Waisglass SE, Dick HLN, Weese JS. Prevalence of meticillin-resistant Staphylococcus pseudintermedius (MRSP) from skin and carriage sites of dogs after treatment of their meticillin-resistant or meticillin-sensitive staphylococcal pyoderma.. Vet Dermatol 23:369–375.
  95. Joffe D, Goulding F, Langelier K, Magyar G, McCurdy L, Milstein M, Nielsen K, Villemaire S. Prevalence of methicillin-resistant staphylococci in canine pyoderma cases in primary care veterinary practices in Canada: a preliminary study.. Can Vet J 56:1084–1086.
    pmc: PMC4572828pubmed: 26483585
  96. Hanselman BA, Kruth SA, Rousseau J, Weese JS. Coagulase positive staphylococcal colonization of humans and their household pets.. Can Vet J 50:954–958.
    pmc: PMC2726022pubmed: 19949556
  97. Guardabassi L, Loeber ME, Jacobson A. Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners.. Vet Microbiol 98:23–27.
    doi: 10.1016/j.vetmic.2003.09.021pubmed: 14738778google scholar: lookup
  98. Frosini SM, Bond R, King R, Feudi C, Schwarz S, Loeffler A. Effect of topical antimicrobial therapy and household cleaning on meticillin-resistant Staphylococcus pseudintermedius carriage in dogs.. Vet Rec 190:e937.
    doi: 10.1002/vetr.937pubmed: 34582577google scholar: lookup
  99. van Duijkeren E, Kamphuis M, van der Mije IC, Laarhoven LM, Duim B, Wagenaar JA, Houwers DJ. Transmission of methicillin-resistant Staphylococcus pseudintermedius between infected dogs and cats and contact pets, humans and the environment in households and veterinary clinics.. Vet Microbiol 150:338–343.
    doi: 10.1016/j.vetmic.2011.02.012pubmed: 21420256google scholar: lookup
  100. van Duijkeren E, Catry B, Greko C, Moreno MA, Pomba MC, Pyörälä S, Ruzauskas M, Sanders P, Threlfall EJ, Torren-Edo J, Törneke K, Scientific Advisory Group on Antimicrobials (SAGAM). Review on methicillin-resistant Staphylococcus pseudintermedius.. J Antimicrob Chemother 66:2705–2714.
    doi: 10.1093/jac/dkr367pubmed: 21930571google scholar: lookup
  101. Shoen HRC, Rose SJ, Ramsey SA, de Morais H, Bermudez LE. Analysis of Staphylococcus infections in a veterinary teaching hospital from 2012 to 2015.. Comp Immunol Microbiol Infect Dis 66:101332.
    doi: 10.1016/j.cimid.2019.101332pubmed: 31437674google scholar: lookup
  102. Perkins AV, Sellon DC, Gay JM, Lofgren ET, Moore DA, Jones LP, Davis MA. Prevalence of methicillin-resistant Staphylococcus pseudintermedius on hand-contact and animal-contact surfaces in companion animal community hospitals.. Can Vet J 61:613–620.
    pmc: PMC7238483pubmed: 32675813
  103. Worthing KA, Brown J, Gerber L, Trott DJ, Abraham S, Norris JM. Methicillin-resistant staphylococci amongst veterinary personnel, personnel-owned pets, patients and the hospital environment of two small animal veterinary hospitals.. Vet Microbiol 223:79–85.
    doi: 10.1016/j.vetmic.2018.07.021pubmed: 30173756google scholar: lookup
  104. Worthing KA, Abraham S, Coombs GW, Pang S, Saputra S, Jordan D, Trott DJ, Norris JM. Clonal diversity and geographic distribution of methicillin-resistant Staphylococcus pseudintermedius from Australian animals: discovery of novel sequence types.. Vet Microbiol 213:58–65.
    doi: 10.1016/j.vetmic.2017.11.018pubmed: 29292005google scholar: lookup
  105. Bergot M, Martins-Simoes P, Kilian H, Châtre P, Worthing KA, Norris JM, Madec JY, Laurent F, Haenni M. Evolution of the Population Structure of Staphylococcus pseudintermedius in France.. Front Microbiol 9:3055.
    doi: 10.3389/fmicb.2018.03055pmc: PMC6300469pubmed: 30619143google scholar: lookup
  106. Nocera FP, Parisi A, Corrente M, De Martino L. Evidence of new sequence types of methicillin-resistant Staphylococcus pseudintermedius in Italy.. Pol J Vet Sci 23:465–468.
    doi: 10.24425/pjvs.2020.134693pubmed: 33006862google scholar: lookup
  107. Kang JH, Hwang CY. First detection of multiresistance pRE25-like elements from Enterococcus spp. in Staphylococcus pseudintermedius isolated from canine pyoderma.. J Glob Antimicrob Resist 20:304–308.
    doi: 10.1016/j.jgar.2019.08.022pubmed: 31493528google scholar: lookup
  108. Phophi L, Abouelkhair M, Jones R, Henton M, Qekwana DN, Kania SA. The molecular epidemiology and antimicrobial resistance of Staphylococcus pseudintermedius canine clinical isolates submitted to a veterinary diagnostic laboratory in South Africa.. PLoS ONE 18:e0290645.
  109. Rynhoud H, Forde BM, Beatson SA, Abraham S, Meler E, Soares Magalhães RJ, Gibson JS. Molecular epidemiology of clinical and colonizing methicillin-resistant Staphylococcus isolates in companion animals.. Front Vet Sci 8:620491.
    doi: 10.3389/fvets.2021.620491pmc: PMC8102687pubmed: 33969030google scholar: lookup
  110. Wielders C, Vriens M, Brisse S, de Graaf-Miltenburg L, Troelstra A, Fleer A, Schmitz F, Verhoef J, Fluit A. Evidence for in-vivo transfer of mecA DNA between strains of Staphylococcus aureus.. The Lancet 357:1674–1675.
    doi: 10.1016/S0140-6736(00)04832-7pubmed: 11425376google scholar: lookup
  111. Maree M, Thi Nguyen LT, Ohniwa RL, Higashide M, Msadek T, Morikawa K. Natural transformation allows transfer of SCCmec-mediated methicillin resistance in Staphylococcus aureus biofilms.. Nat Commun 13:2477.
    doi: 10.1038/s41467-022-29877-2pmc: PMC9072672pubmed: 35513365google scholar: lookup
  112. Ikuta KS, Swetschinski LR, Robles Aguilar G, Sharara F, Mestrovic T, Gray AP, Davis Weaver N, Wool EE, Han C, Gershberg Hayoon A. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.. Lancet 400:2221–2248.
  113. Manges AR, Geum HM, Guo A, Edens TJ, Fibke CD, Pitout JDD. Global extraintestinal pathogenic Escherichia coli (ExPEC) lineages.. Clin Microbiol Rev 32:e00135-18.
    doi: 10.1128/CMR.00135-18pmc: PMC6589867pubmed: 31189557google scholar: lookup
  114. Marques C, Belas A, Franco A, Aboim C, Gama LT, Pomba C. Increase in antimicrobial resistance and emergence of major international high-risk clonal lineages in dogs and cats with urinary tract infection: 16 year retrospective study.. J Antimicrob Chemother 73:377–384.
    doi: 10.1093/jac/dkx401pmc: PMC5890753pubmed: 29136156google scholar: lookup
  115. Chen Y, Liu Z, Zhang Y, Zhang Z, Lei L, Xia Z. Increasing prevalence of ESBL-producing multidrug resistance Escherichia coli from diseased pets in Beijing, China from 2012 to 2017.. Front Microbiol 10:2852.
    doi: 10.3389/fmicb.2019.02852pmc: PMC6915038pubmed: 31921034google scholar: lookup
  116. Jernigan JA, Hatfield KM, Wolford H, Nelson RE, Olubajo B, Reddy SC, McCarthy N, Paul P, McDonald LC, Kallen A, Fiore A, Craig M, Baggs J. Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017.. N Engl J Med 382:1309–1319.
    doi: 10.1056/NEJMoa1914433pmc: PMC10961699pubmed: 32242356google scholar: lookup
  117. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective.. Clin Microbiol Infect 18:646–655.
  118. Belas A, Marques C, Menezes J, da Gama LT, Cavaco-Silva P, Pomba C. ESBL/pAmpC-producing Escherichia coli causing urinary tract infections in non-related companion animals and humans.. Antibiotics (Basel) 11:559.
    doi: 10.3390/antibiotics11050559pmc: PMC9137695pubmed: 35625203google scholar: lookup
  119. Aurich S, Wolf SA, Prenger-Berninghoff E, Thrukonda L, Semmler T, Ewers C. Genotypic characterization of uropathogenic Escherichia coli from companion animals: predominance of ST372 in dogs and human-related ST73 in cats.. Antibiotics (Basel) 13:38.
  120. LeCuyer TE, Byrne BA, Daniels JB, Diaz-Campos DV, Hammac GK, Miller CB, Besser TE, Davis MA. Population structure and antimicrobial resistance of canine uropathogenic Escherichia coli.. J Clin Microbiol 56:e00788-18.
    doi: 10.1128/JCM.00788-18pmc: PMC6113483pubmed: 29997200google scholar: lookup
  121. Elankumaran P, Cummins ML, Browning GF, Marenda MS, Reid CJ, Djordjevic SP. Genomic and Temporal trends in canine ExPEC reflect those of human ExPEC.. Microbiol Spectr 10:e0129122.
    doi: 10.1128/spectrum.01291-22pmc: PMC9241711pubmed: 35674442google scholar: lookup
  122. Liu X, Thungrat K, Boothe DM. Occurrence of OXA-48 carbapenemase and other β-lactamase genes in ESBL-producing multidrug resistant Escherichia coli from dogs and cats in the United States, 2009–2013.. Front Microbiol 7:1057.
    doi: 10.3389/fmicb.2016.01057pmc: PMC4939299pubmed: 27462301google scholar: lookup
  123. Liu X, Liu H, Li Y, Hao C. High prevalence of β-lactamase and plasmid-mediated quinolone resistance genes in extended-spectrum cephalosporin-resistant Escherichia coli from dogs in Shaanxi, China.. Front Microbiol 7:1843.
    doi: 10.3389/fmicb.2016.01843pmc: PMC5111280pubmed: 27899921google scholar: lookup
  124. Bortolami A, Zendri F, Maciuca EI, Wattret A, Ellis C, Schmidt V, Pinchbeck G, Timofte D. Diversity, virulence, and clinical significance of extended-spectrum β-lactamase- and pAmpC-producing Escherichia coli from companion animals.. Front Microbiol 10:1260.
    doi: 10.3389/fmicb.2019.01260pmc: PMC6560200pubmed: 31231344google scholar: lookup
  125. Harada K, Nakai Y, Kataoka Y. Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTX-M-27 β-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan.. Microbiol Immunol 56:480–485.
  126. Zogg AL, Simmen S, Zurfluh K, Stephan R, Schmitt SN, Nüesch-Inderbinen M. High prevalence of extended-spectrum β-lactamase producing Enterobacteriaceae among clinical isolates from cats and dogs admitted to a veterinary hospital in Switzerland.. Front Vet Sci 5:62.
    doi: 10.3389/fvets.2018.00062pmc: PMC5890143pubmed: 29662886google scholar: lookup
  127. Valat C, Drapeau A, Beurlet S, Bachy V, Boulouis HJ, Pin R, Cazeau G, Madec JY, Haenni M. Pathogenic Escherichia coli in dogs reveals the predominance of ST372 and the human-associated ST73 extra-intestinal lineages.. Front Microbiol 11:580.
    doi: 10.3389/fmicb.2020.00580pmc: PMC7186358pubmed: 32373083google scholar: lookup
  128. Stewart AG, Price EP, Schabacker K, Birikmen M, Harris PNA, Choong K, Subedi S, Sarovich DS. Molecular epidemiology of third-generation-cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia.. Antimicrob Agents Chemother 65:e00130-21.
    doi: 10.1128/AAC.00130-21pmc: PMC8315908pubmed: 33781999google scholar: lookup
  129. Liu FL, Kuan NL, Yeh KS. Presence of the extended-spectrum-β-lactamase and plasmid-mediated AmpC-encoding genes in Escherichia coli from companion animals-A study from a university-based veterinary hospital in Taipei, Taiwan.. Antibiotics (Basel) 10:1536.
    doi: 10.3390/antibiotics10121536pmc: PMC8698527pubmed: 34943748google scholar: lookup
  130. Timofte D, Maciuca IE, Williams NJ, Wattret A, Schmidt V. Veterinary hospital dissemination of CTX-M-15 extended-spectrum beta-lactamase-producing Escherichia coli ST410 in the United Kingdom.. Microb Drug Resist 22:609–615.
    doi: 10.1089/mdr.2016.0036pmc: PMC5073239pubmed: 27314838google scholar: lookup
  131. Dahmen S, Haenni M, Chatre P, Madec J-Y. Characterization of blaCTX-M IncFII plasmids and clones of Escherichia coli from pets in France.. J Antimicrob Chemother 68:2797–2801.
    doi: 10.1093/jac/dkt291pubmed: 23852541google scholar: lookup
  132. Silva BA, do Amarante VS, Xavier RGC, Colombo SA, da Silva TF, Brenig B, Aburjaile FF, de Carvalho Azevedo VA, Silva ROS. Characterization of ESBL/AmpC-producing extraintestinal Escherichia coli (ExPEC) in dogs treated at a veterinary hospital in Brazil.. Res Vet Sci 166:105106.
    doi: 10.1016/j.rvsc.2023.105106pubmed: 38086217google scholar: lookup
  133. Campos ACC, Andrade NL, Ferdous M, Chlebowicz MA, Santos CC, Correal JCD, Lo Ten Foe JR, Rosa ACP, Damasco PV, Friedrich AW, Rossen JWA. Comprehensive molecular characterization of Escherichia coli isolates from urine samples of hospitalized patients in Rio de Janeiro, Brazil.. Front Microbiol 9:243.
    doi: 10.3389/fmicb.2018.00243pmc: PMC5821075pubmed: 29503639google scholar: lookup
  134. Voor In ’t Holt AF, Wattel AA, Boers SA, Jansen R, Hays JP, Goessens WHF, Vos MC. Detection of healthcare-related extended-spectrum beta-lactamase-producing Escherichia coli transmission events using combined genetic and phenotypic epidemiology.. PLoS One 11:e0160156.
  135. Melo LC, Oresco C, Leigue L, Netto HM, Melville PA, Benites NR, Saras E, Haenni M, Lincopan N, Madec JY. Prevalence and molecular features of ESBL/pAmpC-producing Enterobacteriaceae in healthy and diseased companion animals in Brazil.. Vet Microbiol 221:59–66.
    doi: 10.1016/j.vetmic.2018.05.017pubmed: 29981709google scholar: lookup
  136. Hertz FB, Nielsen JB, Schønning K, Littauer P, Knudsen JD, Løbner-Olesen A, Frimodt-Møller N. Population structure of drug-susceptible,-resistant and ESBL-producing Escherichia coli from community-acquired urinary tract.. BMC Microbiol 16:63.
    doi: 10.1186/s12866-016-0681-zpmc: PMC4827192pubmed: 27067536google scholar: lookup
  137. Kang CI, Cha MK, Kim SH, Ko KS, Wi YM, Chung DR, Peck KR, Lee NY, Song JH. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.. J Korean Med Sci 28:998–1004.
    doi: 10.3346/jkms.2013.28.7.998pmc: PMC3708098pubmed: 23853481google scholar: lookup
  138. Ha YE, Kang CI, Cha MK, Park SY, Wi YM, Chung DR, Peck KR, Lee NY, Song JH. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.. Int J Antimicrob Agents 42:403–409.
  139. Miao Z, Li S, Wang L, Song W, Zhou Y. Antimicrobial resistance and molecular epidemiology of ESBL-producing Escherichia coli isolated from outpatients in town hospitals of Shandong Province, China.. Front Microbiol 8:63.
    doi: 10.3389/fmicb.2017.00063pmc: PMC5258711pubmed: 28174570google scholar: lookup
  140. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group.. Clin Microbiol Rev 27:543–574.
    doi: 10.1128/CMR.00125-13pmc: PMC4135899pubmed: 24982321google scholar: lookup
  141. Pitout JDD, DeVinney R. Escherichia coli ST131: a multidrug-resistant clone primed for global domination.. F1000Res 6:195.
  142. Kidsley AK, White RT, Beatson SA, Saputra S, Schembri MA, Gordon D, Johnson JR, O’Dea M, Mollinger JL, Abraham S, Trott DJ. Companion animals are spillover hosts of the multidrug-resistant human extraintestinal Escherichia coli pandemic clones ST131 and ST1193.. Front Microbiol 11:1968.
    doi: 10.3389/fmicb.2020.01968pmc: PMC7492567pubmed: 32983008google scholar: lookup
  143. Manges AR, Johnson JR. Reservoirs of extraintestinal pathogenic Escherichia coli.. Microbiol Spectr 3.
  144. Day MJ, Hopkins KL, Wareham DW, Toleman MA, Elviss N, Randall L, Teale C, Cleary P, Wiuff C, Doumith M, Ellington MJ, Woodford N, Livermore DM. Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study.. Lancet Infect Dis 19:1325–1335.
    doi: 10.1016/S1473-3099(19)30273-7pubmed: 31653524google scholar: lookup
  145. Biggel M, Hoehn S, Frei A, Dassler K, Jans C, Stephan R. Dissemination of ESBL-producing E. coli ST131 through wastewater and environmental water in Switzerland.. Environ Pollut 337:122476.
    doi: 10.1016/j.envpol.2023.122476pubmed: 37659628google scholar: lookup
  146. Pomba C, da Fonseca JD, Baptista BC, Correia JD, Martínez-Martínez L. Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6’)-Ib-cr genes in a dog.. Antimicrob Agents Chemother 53:327–328.
    doi: 10.1128/AAC.00896-08pmc: PMC2612186pubmed: 19001117google scholar: lookup
  147. Li D, Wyrsch ER, Elankumaran P, Dolejska M, Marenda MS, Browning GF, Bushell RN, McKinnon J, Chowdhury PR, Hitchick N, Miller N, Donner E, Drigo B, Baker D, Charles IG, Kudinha T, Jarocki VM, Djordjevic SP. Genomic comparisons of Escherichia coli ST131 from Australia.. Microb Genom 7:000721.
    doi: 10.1099/mgen.0.000721pmc: PMC8767332pubmed: 34910614google scholar: lookup
  148. Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan M-D, Gomes Moriel D, Peters KM, Davies M, Rogers BA, Dougan G, Rodriguez-Baño J, Pascual A, Pitout JDD, Upton M, Paterson DL, Walsh TR, Schembri MA, Beatson SA. Global dissemination of a multidrug resistant Escherichia coli clone.. Proc Natl Acad Sci U S A 111:5694–5699.
    doi: 10.1073/pnas.1322678111pmc: PMC3992628pubmed: 24706808google scholar: lookup
  149. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.. MBio 4:e00377–13.
    doi: 10.1128/mBio.00377-13pmc: PMC3870262pubmed: 24345742google scholar: lookup
  150. Matsumura Y, Pitout JDD, Gomi R, Matsuda T, Noguchi T, Yamamoto M, Peirano G, DeVinney R, Bradford PA, Motyl MR, Tanaka M, Nagao M, Takakura S, Ichiyama S. Global Escherichia coli sequence type 131 clade with blaCTX-M-27 gene.. Emerg Infect Dis 22:1900–1907.
    doi: 10.3201/eid2211.160519pmc: PMC5088012pubmed: 27767006google scholar: lookup
  151. Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.. J Antimicrob Chemother 65:651–660.
    doi: 10.1093/jac/dkq004pubmed: 20118165google scholar: lookup
  152. Melo LC, Haenni M, Saras E, Duprilot M, Nicolas-Chanoine MH, Madec JY. Emergence of the C1-M27 cluster in ST131 Escherichia coli from companion animals in France.. J Antimicrob Chemother 74:3111–3113.
    doi: 10.1093/jac/dkz304pubmed: 31299071google scholar: lookup
  153. Johnson JR, Davis G, Clabots C, Johnston BD, Porter S, DebRoy C, Pomputius W, Ender PT, Cooperstock M, Slater BS, Banerjee R, Miller S, Kisiela D, Sokurenko EV, Aziz M, Price LB. Household clustering of Escherichia coli sequence type 131 clinical and fecal isolates according to whole genome sequence analysis.. Open Forum Infect Dis 3:fw129.
    doi: 10.1093/ofid/ofw129pmc: PMC5047392pubmed: 27703993google scholar: lookup
  154. Muller A, Gbaguidi-Haore H, Cholley P, Hocquet D, Sauget M, Bertrand X. Hospital-diagnosed infections with Escherichia coli clonal group ST131 are mostly acquired in the community.. Sci Rep 11:5702.
    doi: 10.1038/s41598-021-85116-6pmc: PMC7952690pubmed: 33707589google scholar: lookup
  155. Torres E, López-Cerero L, Morales I, Navarro MD, Rodríguez-Baño J, Pascual A. Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients.. Clin Microbiol Infect 24:618–623.
    doi: 10.1016/j.cmi.2017.09.007pubmed: 28939488google scholar: lookup
  156. Whitmer GR, Moorthy G, Arshad M. The pandemic Escherichia coli sequence type 131 strain is acquired even in the absence of antibiotic exposure.. PLoS Pathog 15:e1008162.
  157. Johnson JR, Miller S, Johnston B, Clabots C, DebRoy C. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household .. J Clin Microbiol 47:3721–3725.
    doi: 10.1128/JCM.01581-09pmc: PMC2772598pubmed: 19710261google scholar: lookup
  158. Ukah UV, Glass M, Avery B, Daignault D, Mulvey MR, Reid-Smith RJ, Parmley EJ, Portt A, Boerlin P, Manges AR. Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract infections.. Epidemiol Infect 146:46–57.
    doi: 10.1017/S0950268817002680pmc: PMC9134527pubmed: 29229015google scholar: lookup
  159. van den Bunt G, van Pelt W, Hidalgo L, Scharringa J, de Greeff SC, Schürch AC, Mughini-Gras L, Bonten MJM, Fluit AC. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.. Euro Surveill 24:pii.
  160. Søraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing Enterobacteriaceae--a case-control study in a low prevalence country.. PLoS One 8:e69581.
  161. Salamanca-Rivera E, López-Cerero L, Rodríguez-Martínez JM, Pascual A, Rodríguez-Baño J. Prevalence, incidence, and risk factors for intestinal colonization due to fluoroquinolone-resistant ST131 Escherichia coli: a longitudinal study in highly dependent, long-term care facility residents.. Microbiol Spectr 10:e0167322.
    doi: 10.1128/spectrum.01673-22pmc: PMC9431526pubmed: 35943257google scholar: lookup
  162. Apostolakos I, Franz E, van Hoek AHAM, Florijn A, Veenman C, Sloet-van Oldruitenborgh-Oosterbaan MM, Dierikx C, van Duijkeren E. Occurrence and molecular characteristics of ESBL/AmpC-producing Escherichia coli in faecal samples from horses in an equine clinic.. J Antimicrob Chemother 72:1915–1921.
    doi: 10.1093/jac/dkx072pubmed: 28333298google scholar: lookup
  163. Cummins EA, Snaith AE, McNally A, Hall RJ. The role of potentiating mutations in the evolution of pandemic Escherichia coli clones.. Eur J Clin Microbiol Infect Dis .
    doi: 10.1007/s10096-021-04359-3pubmed: 34787747google scholar: lookup
  164. Roer L, Overballe-Petersen S, Hansen F, Schønning K, Wang M, Røder BL, Hansen DS, Justesen US, Andersen LP, Fulgsang-Damgaard D, Hopkins KL, Woodford N, Falgenhauer L, Chakraborty T, Samuelsen Ø, Sjöström K, Johannesen TB, Ng K, Nielsen J, Ethelberg S, Stegger M, Hammerum AM, Hasman H. Escherichia coli sequence type 410 is causing new international high-risk clones .. mSphere 3:337–355.
    doi: 10.1128/mSphere.00337-18pmc: PMC6052333pubmed: 30021879google scholar: lookup
  165. Pitout JDD, Peirano G, Matsumura Y, DeVinney R, Chen L. Escherichia coli sequence type 410 with carbapenemases: a paradigm shift within E. coli toward multidrug resistance.. Antimicrob Agents Chemother 68:e0133923.
    doi: 10.1128/aac.01339-23pmc: PMC10869336pubmed: 38193668google scholar: lookup
  166. Schaufler K, Semmler T, Wieler LH, Wöhrmann M, Baddam R, Ahmed N, Müller K, Kola A, Fruth A, Ewers C, Guenther S. Clonal spread and interspecies transmission of clinically relevant ESBL-producing Escherichia coli of ST410--another successful pandemic clone?. FEMS Microbiol Ecol 92:fiv155.
    doi: 10.1093/femsec/fiv155pubmed: 26656065google scholar: lookup
  167. Falgenhauer L, Imirzalioglu C, Ghosh H, Gwozdzinski K, Schmiedel J, Gentil K, Bauerfeind R, Kämpfer P, Seifert H, Michael GB, Schwarz S, Pfeifer Y, Werner G, Pietsch M, Roesler U, Guerra B, Fischer J, Sharp H, Käsbohrer A, Goesmann A, Hille K, Kreienbrock L, Chakraborty T. Circulation of clonal populations of fluoroquinolone-resistant CTX-M-15-producing Escherichia coli ST410 in humans and animals in Germany.. Int J Antimicrob Agents 47:457–465.
  168. Johansson V, Nykäsenoja S, Myllyniemi AL, Rossow H, Heikinheimo A. Genomic characterization of ESBL/AmpC-producing and high-risk clonal lineages of Escherichia coli and Klebsiella pneumoniae in imported dogs with shelter and stray background.. J Glob Antimicrob Resist 30:183–190.
    doi: 10.1016/j.jgar.2022.05.021pubmed: 35640866google scholar: lookup
  169. Yamaji R, Rubin J, Thys E, Friedman CR, Riley LW. Persistent pandemic lineages of uropathogenic Escherichia coli in a college community from 1999 to 2017.. J Clin Microbiol 56:e01834-17.
    doi: 10.1128/JCM.01834-17pmc: PMC5869836pubmed: 29436416google scholar: lookup
  170. Riley LW. Pandemic lineages of extraintestinal pathogenic Escherichia coli.. Clin Microbiol Infect 20:380–390.
    doi: 10.1111/1469-0691.12646pubmed: 24766445google scholar: lookup
  171. Melo LC, Boisson MNG, Saras E, Médaille C, Boulouis H-J, Madec J-Y, Haenni M. OXA-48-producing ST372 Escherichia coli in a French dog.. J Antimicrob Chemother 72:1256–1258.
    doi: 10.1093/jac/dkw531pubmed: 28039279google scholar: lookup
  172. Elankumuran P, Browning GF, Marenda MS, Kidsley A, Osman M, Haenni M, Johnson JR, Trott DJ, Reid CJ, Djordjevic SP. Identification of genes influencing the evolution of Escherichia coli ST372 in dogs and humans.. Microb Genom 9:000930.
    doi: 10.1099/mgen.0.000930pmc: PMC9997745pubmed: 36752777google scholar: lookup
  173. Mughini-Gras L, Dorado-García A, van Duijkeren E, van den Bunt G, Dierikx CM, Bonten MJM, Bootsma MCJ, Schmitt H, Hald T, Evers EG, de Koeijer A, van Pelt W, Franz E, Mevius DJ, Heederik DJJ, ESBL Attribution Consortium. Attributable sources of community-acquired carriage of Escherichia coli containing β-lactam antibiotic resistance genes: a population-based modelling study.. Lancet Planet Health 3:e357–e369.
    doi: 10.1016/S2542-5196(19)30130-5pubmed: 31439317google scholar: lookup
  174. Cocker D, Chidziwisano K, Mphasa M, Mwapasa T, Lewis JM, Rowlingson B, Sammarro M, Bakali W, Salifu C, Zuza A. Investigating one health risks for human colonisation with extended spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Malawian households: a longitudinal cohort study.. Lancet Microbe 4:e534–e543.
  175. Berendes D, Kirby A, Brown J, Wester AL. Human faeces-associated extended-spectrum β-lactamase-producing Escherichia coli discharge into sanitation systems in 2015 and 2030: a global and regional analysis.. Lancet Planet Health 4:e246–e255.
  176. Huang YH, Kuan NL, Yeh KS. Characteristics of extended-spectrum β-lactamase-producing Escherichia coli from dogs and cats admitted to a veterinary teaching hospital in Taipei, Taiwan From 2014 to 2017.. Front Vet Sci 7:395.
    doi: 10.3389/fvets.2020.00395pmc: PMC7378734pubmed: 32766294google scholar: lookup
  177. Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection.. JAC Antimicrob Resist 3:dlab092.
    doi: 10.1093/jacamr/dlab092pmc: PMC8284625pubmed: 34286272google scholar: lookup
  178. Salgado-Caxito M, Benavides JA, Adell AD, Paes AC, Moreno-Switt AI. Global prevalence and molecular characterization of extended-spectrum β-lactamase producing-Escherichia coli in dogs and cats - A scoping review and meta-analysis.. One Health 12:100236.
  179. Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis.. Clin Infect Dis 63:310–318.
    doi: 10.1093/cid/ciw283pubmed: 27143671google scholar: lookup
  180. Bezabih YM, Sabiiti W, Alamneh E, Bezabih A, Peterson GM, Bezabhe WM, Roujeinikova A. The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community.. J Antimicrob Chemother 76:22–29.
    doi: 10.1093/jac/dkaa399pubmed: 33305801google scholar: lookup
  181. Ramos CP, Kamei CYI, Viegas FM, de Melo Barbieri J, Cunha JLR, Hounmanou YMG, Coura FM, Santana JA, Lobato FCF, Bojesen AM, Silva ROS. Fecal shedding of multidrug resistant Escherichia coli isolates in dogs fed with raw meat-based diets in Brazil.. Antibiotics (Basel) 11:534.
    doi: 10.3390/antibiotics11040534pmc: PMC9029118pubmed: 35453285google scholar: lookup
  182. Sobkowich KE, Weese JS, Poljak Z, Plum A, Szlosek D, Bernardo TM. Epidemiology of companion animal AMR in the United States of America: filling a gap in the one health approach.. Front Public Health 11:1161950.
    doi: 10.3389/fpubh.2023.1161950pmc: PMC10313394pubmed: 37397773google scholar: lookup
  183. Shaheen BW, Nayak R, Foley SL, Kweon O, Deck J, Park M, Rafii F, Boothe DM. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.. Antimicrob Agents Chemother 55:5666–5675.
    doi: 10.1128/AAC.00656-11pmc: PMC3232758pubmed: 21947397google scholar: lookup
  184. Huber H, Zweifel C, Wittenbrink MM, Stephan R. ESBL-producing uropathogenic Escherichia coli isolated from dogs and cats in Switzerland.. Vet Microbiol 162:992–996.
    doi: 10.1016/j.vetmic.2012.10.029pubmed: 23177909google scholar: lookup
  185. European Medicines Agency. Sales of veterinary antimicrobial agents in 29 European countries in 2014 – trends from 2011 to 2014 – Sixth ESVAC report.. European Medicines Agency 2016.
  186. Weese JS, Mosher M, Low R, West E, O’Kelley B, Morrison JA, Kimmerlein A, St Bernard S, Blackie K, Gronlund U, Battersby I. Evaluation of antimicrobial purchasing by companion animal veterinary facilities in Canada, the United Kingdom, and the United States of America (2019-2021).. J Vet Intern Med 38:1520–1534.
    doi: 10.1111/jvim.17068pmc: PMC11099783pubmed: 38660791google scholar: lookup
  187. DTU. DANMAP 2022 -use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark.. 2022.
  188. Johnson JR, Clabots C, Kuskowski MA. Multiple-host sharing, long-term persistence, and virulence of Escherichia coli Clones from human and animal household members .. J Clin Microbiol 46:4078–4082.
    doi: 10.1128/JCM.00980-08pmc: PMC2593269pubmed: 18945846google scholar: lookup
  189. Carvalho AC, Barbosa AV, Arais LR, Ribeiro PF, Carneiro VC, Cerqueira AMF. Resistance patterns, ESBL genes, and genetic relatedness of Escherichia coli from dogs and owners.. Braz J Microbiol 47:150–158.
    doi: 10.1016/j.bjm.2015.11.005pmc: PMC4822764pubmed: 26887238google scholar: lookup
  190. van den Bunt G, Fluit AC, Spaninks MP, Timmerman AJ, Geurts Y, Kant A, Scharringa J, Mevius D, Wagenaar JA, Bonten MJM, van Pelt W, Hordijk J. Faecal carriage, risk factors, acquisition and persistence of ESBL-producing Enterobacteriaceae in dogs and cats and co-carriage with humans belonging to the same household.. J Antimicrob Chemother 75:342–350.
    doi: 10.1093/jac/dkz462pmc: PMC6966097pubmed: 31711228google scholar: lookup
  191. Reeves PR, Liu B, Zhou Z, Li D, Guo D, Ren Y, Clabots C, Lan R, Johnson JR, Wang L. Rates of mutation and host transmission for an Escherichia coli clone over 3 Years.. PLoS ONE 6:e26907.
  192. Hilty M, Betsch BY, Bögli-Stuber K, Heiniger N, Stadler M, Küffer M, Kronenberg A, Rohrer C, Aebi S, Endimiani A, Droz S, Mühlemann K. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting.. Clin Infect Dis 55:967–975.
    doi: 10.1093/cid/cis581pmc: PMC3436924pubmed: 22718774google scholar: lookup
  193. Marques C, Menezes J, Belas A, Aboim C, Cavaco-Silva P, Trigueiro G, Telo Gama L, Pomba C. Klebsiella pneumoniae causing urinary tract infections in companion animals and humans: population structure, antimicrobial resistance and virulence genes.. J Antimicrob Chemother 74:594–602.
    doi: 10.1093/jac/dky499pubmed: 30535393google scholar: lookup
  194. Marques C, Belas A, Aboim C, Cavaco-Silva P, Trigueiro G, Gama LT, Pomba C. Evidence of sharing of Klebsiella pneumoniae strains between healthy companion animals and cohabiting humans.. J Clin Microbiol 57:e01537–18.
    doi: 10.1128/JCM.01537-18pmc: PMC6535590pubmed: 30944193google scholar: lookup
  195. Reuland EA, Al Naiemi N, Kaiser AM, Heck M, Kluytmans J, Savelkoul PHM, Elders PJM, Vandenbroucke-Grauls CMJE. Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam.. J Antimicrob Chemother 71:1076–1082.
    doi: 10.1093/jac/dkv441pmc: PMC4790620pubmed: 26755493google scholar: lookup
  196. van Dulm E, Tholen ATR, Pettersson A, van Rooijen MS, Willemsen I, Molenaar P, Damen M, Gruteke P, Oostvogel P, Kuijper EJ, Hertogh CMPM, Vandenbroucke-Grauls CMJE, Scholing M. High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands.. PLoS One 14:e0222200.
  197. Meijs AP, Gijsbers EF, Hengeveld PD, Dierikx CM, de Greeff SC, van Duijkeren E. ESBL/pAmpC-producing Escherichia coli and Klebsiella pneumoniae carriage among veterinary healthcare workers in the Netherlands.. Antimicrob Resist Infect Control 10:147.
    doi: 10.1186/s13756-021-01012-8pmc: PMC8524829pubmed: 34666826google scholar: lookup
  198. Isgren CM, Edwards T, Pinchbeck GL, Winward E, Adams ER, Norton P, Timofte D, Maddox TW, Clegg PD, Williams NJ. Emergence of carriage of CTX-M-15 in faecal Escherichia coli in horses at an equine hospital in the UK; increasing prevalence over a decade (2008-2017).. BMC Vet Res 15:268.
    doi: 10.1186/s12917-019-2011-9pmc: PMC6664770pubmed: 31357996google scholar: lookup
  199. World Health Organization. WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance.. 2024.
  200. Patel G, Bonomo RA. “Stormy waters ahead”: global emergence of carbapenemases.. Front Microbiol 4:48.
    doi: 10.3389/fmicb.2013.00048pmc: PMC3596785pubmed: 23504089google scholar: lookup
  201. Ramírez-Castillo FY, Guerrero-Barrera AL, Avelar-González FJ. An overview of carbapenem-resistant organisms from food-producing animals, seafood, aquaculture, companion animals, and wildlife.. Front Vet Sci 10:1158588.
    doi: 10.3389/fvets.2023.1158588pmc: PMC10311504pubmed: 37397005google scholar: lookup
  202. Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom 5:e000306.
    doi: 10.1099/mgen.0.000306pmc: PMC6861865pubmed: 31599224google scholar: lookup
  203. Wang M-G, Fang C, Liu K-D, Wang L-L, Sun R-Y, Zhang R-M, Fang L-X, Sun J, Liu Y-H, Liao X-P. Transmission and molecular characteristics of blaNDM-producing Escherichia coli between companion animals and their healthcare providers in Guangzhou, China.. J Antimicrob Chemother 77:351–355.
    doi: 10.1093/jac/dkab382pubmed: 34726693google scholar: lookup
  204. Cole SD, Peak L, Tyson GH, Reimschuessel R, Ceric O, Rankin SC. New Delhi metallo-β-lactamase-5-producing Escherichia coli in companion animals, United States.. Emerg Infect Dis 26:381–383.
    doi: 10.3201/eid2602.191221pmc: PMC6986821pubmed: 31961309google scholar: lookup
  205. Nigg A, Brilhante M, Dazio V, Clément M, Collaud A, Gobeli Brawand S, Willi B, Endimiani A, Schuller S, Perreten V. Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018.. Euro Surveill 24:1900071.
  206. Grönthal T, Österblad M, Eklund M, Jalava J, Nykäsenoja S, Pekkanen K, Rantala M. Sharing more than friendship - transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family, Finland, 2015.. Euro Surveill 23:1700497.
  207. Garcia-Fierro R, Drapeau A, Dazas M, Saras E, Rodrigues C, Brisse S, Madec JY, Haenni M. Comparative phylogenomics of ESBL-, AmpC- and carbapenemase-producing Klebsiella pneumoniae originating from companion animals and humans.. J Antimicrob Chemother 77:1263–1271.
    doi: 10.1093/jac/dkac041pmc: PMC9047677pubmed: 35224624google scholar: lookup
  208. Brilhante M, Gobeli Brawand S, Endimiani A, Rohrbach H, Kittl S, Willi B, Schuller S, Perreten V. Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral hospital.. J Antimicrob Chemother 76:1140–1149.
    doi: 10.1093/jac/dkab028pubmed: 33615354google scholar: lookup
  209. Leelapsawas C, Yindee J, Nittayasut N, Chueahiran S, Boonkham P, Suanpairintr N, Chanchaithong P. Emergence and multi-lineages of carbapenemase-producing Acinetobacter baumannii-calcoaceticus complex from canine and feline origins.. J Vet Med Sci 84:1377–1384.
    doi: 10.1292/jvms.22-0276pmc: PMC9586037pubmed: 36031361google scholar: lookup
  210. Fernandes MR, Sellera FP, Moura Q, Carvalho MPN, Rosato PN, Cerdeira L, Lincopan N. Zooanthroponotic transmission of drug-resistant Pseudomonas aeruginosa, Brazil .. Emerg Infect Dis 24:1160–1162.
    doi: 10.3201/eid2406.180335pmc: PMC6004847pubmed: 29774849google scholar: lookup
  211. Wang Y, Wang X, Schwarz S, Zhang R, Lei L, Liu X, Lin D, Shen J. IMP-45-producing multidrug-resistant Pseudomonas aeruginosa of canine origin.. J Antimicrob Chemother 69:2579–2581.
    doi: 10.1093/jac/dku133pubmed: 24777897google scholar: lookup
  212. Hyun JE, Chung TH, Hwang CY. Identification of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from dogs with pyoderma and otitis in Korea.. Vet Dermatol 29:186–e68.
    doi: 10.1111/vde.12534pubmed: 29575185google scholar: lookup
  213. Tyson GH, Li C, Ceric O, Reimschuessel R, Cole S, Peak L, Rankin SC. Complete genome sequence of a carbapenem-resistant Escherichia coli isolate with blaNDM-5 from a dog in the United States.. Microbiol Resour Announc 8:e00872-19.
    doi: 10.1128/MRA.00872-19pmc: PMC6706697pubmed: 31439705google scholar: lookup
  214. Wang H, Li X, Liu BT. Occurrence and characterization of KPC-2-producing ST11 Klebsiella pneumoniae isolate and NDM-5-producing Escherichia coli isolate from the same horse of equestrian clubs in China.. Transbound Emerg Dis 68:224–232.
    doi: 10.1111/tbed.13614pubmed: 32386080google scholar: lookup
  215. Taj Z, Rasool MH, Almatroudi A, Saqalein M, Khurshid M. Extensively drug-resistant Acinetobacter baumannii belonging to international Clone II from a pet cat with urinary tract infection; the first report from Pakistan.. Pol J Microbiol 69:1–4.
    doi: 10.33073/pjm-2020-017pmc: PMC7324854pubmed: 32343078google scholar: lookup
  216. Stolle I, Prenger-Berninghoff E, Stamm I, Scheufen S, Hassdenteufel E, Guenther S, Bethe A, Pfeifer Y, Ewers C. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs.. J Antimicrob Chemother 68:2802–2808.
    doi: 10.1093/jac/dkt259pubmed: 23833179google scholar: lookup
  217. Sellera FP, Fuga B, Fontana H, Esposito F, Cardoso B, Konno S, Berl C, Cappellanes MH, Cortez M, Ikeda M, de Souza CM, Cerdeira L, Lincopan N. Detection of IncN-pST15 one-health plasmid harbouring blaKPC-2 in a hypermucoviscous Klebsiella pneumoniae CG258 isolated from an infected dog, Brazil.. Transbound Emerg Dis 68:3083–3088.
    doi: 10.1111/tbed.14006pmc: PMC9290030pubmed: 33507616google scholar: lookup
  218. Sellera FP, Fernandes MR, Ruiz R, Falleiros ACM, Rodrigues FP, Cerdeira L, Lincopan N. Identification of KPC-2-producing Escherichia coli in a companion animal: a new challenge for veterinary clinicians.. J Antimicrob Chemother 73:2259–2261.
    doi: 10.1093/jac/dky173pubmed: 29800301google scholar: lookup
  219. Kyung SM, Choi S-W, Lim J, Shim S, Kim S, Im YB, Lee N-E, Hwang C-Y, Kim D, Yoo HS. Comparative genomic analysis of plasmids encoding metallo-β-lactamase NDM-5 in Enterobacterales Korean isolates from companion dogs.. Sci Rep 12:1569.
    doi: 10.1038/s41598-022-05585-1pmc: PMC8799648pubmed: 35091689google scholar: lookup
  220. Reynolds ME, Phan HTT, George S, Hubbard ATM, Stoesser N, Maciuca IE, Crook DW, Timofte D. Occurrence and characterization of Escherichia coli ST410 co-harbouring blaNDM-5, blaCMY-42 and blaTEM-190 in a dog from the UK.. J Antimicrob Chemother 74:1207–1211.
    doi: 10.1093/jac/dkz017pubmed: 30753576google scholar: lookup
  221. Pomba C, Endimiani A, Rossano A, Saial D, Couto N, Perreten V. First report of OXA-23-mediated carbapenem resistance in sequence type 2 multidrug-resistant Acinetobacter baumannii associated with urinary tract infection in a cat.. Antimicrob Agents Chemother 58:1267–1268.
    doi: 10.1128/AAC.02527-13pmc: PMC3910809pubmed: 24295971google scholar: lookup
  222. Nittayasut N, Yindee J, Boonkham P, Yata T, Suanpairintr N, Chanchaithong P. Multiple and high-risk clones of extended-spectrum cephalosporin-resistant and blaNDM-5-harbouring uropathogenic Escherichia coli from cats and dogs in Thailand.. Antibiotics (Basel) 10:1374.
    doi: 10.3390/antibiotics10111374pmc: PMC8614778pubmed: 34827312google scholar: lookup
  223. Jacobmeyer L, Semmler T, Stamm I, Ewers C. Genomic Analysis of Acinetobacter baumannii isolates carrying OXA-23 and OXA-58 genes from animals reveals ST1 and ST25 as major clonal lineages.. Antibiotics (Basel) 11:1045.
    doi: 10.3390/antibiotics11081045pmc: PMC9404926pubmed: 36009914google scholar: lookup
  224. Kuang X, Yang R, Ye X, Sun J, Liao X, Liu Y, Yu Y. NDM-5-producing Escherichia coli co-harboring mcr-1 gene in companion animals in China.. Animals (Basel) 12:1310.
    doi: 10.3390/ani12101310pmc: PMC9137672pubmed: 35625156google scholar: lookup
  225. Hong JS, Song W, Park HM, Oh JY, Chae JC, Han JI, Jeong SH. First detection of New Delhi metallo-β-lactamase-5-producing Escherichia coli from companion animals in Korea.. Microb Drug Resist 25:344–349.
    doi: 10.1089/mdr.2018.0237pubmed: 30379599google scholar: lookup
  226. Lupo A, Châtre P, Ponsin C, Saras E, Boulouis HJ, Keck N, Haenni M, Madec JY. Clonal spread of Acinetobacter baumannii sequence type 25 carrying blaOXA-23 in companion animals in France.. Antimicrob Agents Chemother 61:e01881-16.
    doi: 10.1128/AAC.01881-16pmc: PMC5192103pubmed: 27799214google scholar: lookup
  227. Haenni M, Boulouis HJ, Lagrée AC, Drapeau A, Va F, Billet M, Châtre P, Madec JY. Enterobacterales high-risk clones and plasmids spreading blaESBL/AmpC and blaOXA-48 genes within and between hospitalized dogs and their environment.. J Antimicrob Chemother 77:2754–2762.
    doi: 10.1093/jac/dkac268pubmed: 35983589google scholar: lookup
  228. Cole SD, Rankin SC. Characterization of 2 Klebsiella pneumoniae carbapenemase-producing Enterobacterales isolated from canine rectal swabs.. J Vet Diagn Invest 34:306–309.
    doi: 10.1177/10406387211065501pmc: PMC8921797pubmed: 34931554google scholar: lookup
  229. Brookshire C, Robinson D, Seo K. Carbapenemase-producing ST307 Klebsiella pneumoniae in dogs.. Am J Med Sci 365:S313–S314.
  230. Brilhante M, Menezes J, Belas A, Feudi C, Schwarz S, Pomba C, Perreten V. OXA-181-Producing extraintestinal pathogenic Escherichia coli sequence type 410 isolated from a dog in Portugal.. Antimicrob Agents Chemother 64:e02298-19.
    doi: 10.1128/AAC.02298-19pmc: PMC7179305pubmed: 31964797google scholar: lookup
  231. Batisti Biffignandi G, Piazza A, Marchesini F, Prati P, Mercato A, Abu Alshaar A, Andreoli G, Sassera D, Migliavacca R. Genomic characterization of an O101:H9-ST167 NDM-5-producing Escherichia coli strain from a Kitten in Italy.. Microbiol Spectr 10:e0083222.
    doi: 10.1128/spectrum.00832-22pmc: PMC9241605pubmed: 35665628google scholar: lookup
  232. Hong JS, Song W, Jeong SH. Molecular characteristics of NDM-5-producing Escherichia coli from a cat and a dog in South Korea.. Microb Drug Resist 26:1005–1008.
    doi: 10.1089/mdr.2019.0382pubmed: 32043911google scholar: lookup
  233. Ewers C, Klotz P, Leidner U, Stamm I, Prenger-Berninghoff E, Göttig S, Semmler T, Scheufen S. OXA-23 and ISAba1-OXA-66 class D β-lactamases in Acinetobacter baumannii isolates from companion animals.. Int J Antimicrob Agents 49:37–44.
  234. Alba P, Taddei R, Cordaro G, Fontana MC, Toschi E, Gaibani P, Marani I, Giacomi A, Diaconu EL, Iurescia M, Carfora V, Franco A. Carbapenemase IncF-borne blaNDM-5 gene in the E. coli ST167 high-risk clone from canine clinical infection, Italy.. Vet Microbiol 256:109045.
    doi: 10.1016/j.vetmic.2021.109045pubmed: 33887564google scholar: lookup
  235. Peirano G, Chen L, Nobrega D, Finn TJ, Kreiswirth BN, DeVinney R, Pitout JDD. Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015-2017.. Emerg Infect Dis 28:924–931.
    doi: 10.3201/eid2805.212535pmc: PMC9045447pubmed: 35451367google scholar: lookup
  236. Yang QE, Ma X, Zeng L, Wang Q, Li M, Teng L, He M, Liu C, Zhao M, Wang M, Hui D, Madsen JS, Liao H, Walsh TR, Zhou S. Interphylum dissemination of NDM-5-positive plasmids in hospital wastewater from Fuzhou, China: a single-centre, culture-independent, plasmid transmission study.. Lancet Microbe 5:e13–e23.
    doi: 10.1016/S2666-5247(23)00227-6pubmed: 38006896google scholar: lookup
  237. Endimiani A, Brilhante M, Bernasconi OJ, Perreten V, Schmidt JS, Dazio V, Nigg A, Gobeli Brawand S, Kuster SP, Schuller S, Willi B. Employees of Swiss veterinary clinics colonized with epidemic clones of carbapenemase-producing Escherichia coli.. J Antimicrob Chemother 75:766–768.
    doi: 10.1093/jac/dkz470pubmed: 31819979google scholar: lookup
  238. Peterhans S, Stevens MJA, Nüesch-Inderbinen M, Schmitt S, Stephan R, Zurfluh K. First report of a blaNDM-5-harbouring Escherichia coli ST167 isolated from a wound infection in a dog in Switzerland.. J Glob Antimicrob Resist 15:226–227.
    doi: 10.1016/j.jgar.2018.10.013pubmed: 30339894google scholar: lookup
  239. Hayashi W, Izumi K, Yoshida S, Takizawa S, Sakaguchi K, Iyori K, Minoshima K-I, Takano S, Kitagawa M, Nagano Y, Nagano N. Antimicrobial resistance and type III secretion system virulotypes of Pseudomonas aeruginosa isolates from dogs and cats in primary veterinary hospitals in japan: identification of the international high-risk clone sequence type 235.. Microbiol Spectr 9:e0040821.
    doi: 10.1128/Spectrum.00408-21pmc: PMC8557929pubmed: 34585944google scholar: lookup
  240. Haenni M, Bour M, Châtre P, Madec JY, Plésiat P, Jeannot K. Resistance of animal strains of Pseudomonas aeruginosa to carbapenems.. Front Microbiol 8:1847.
    doi: 10.3389/fmicb.2017.01847pmc: PMC5626926pubmed: 29033910google scholar: lookup
  241. Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.. Lancet Microbe 4:e159–e170.
  242. Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.. Lancet Reg Health Eur 34:100736.
  243. Yano H, Hayashi W, Kawakami S, Aoki S, Anzai E, Zuo H, Kitamura N, Hirabayashi A, Kajihara T, Kayama S, Sugawara Y, Yahara K, Sugai M. Nationwide genome surveillance of carbapenem-resistant Pseudomonas aeruginosa in Japan.. Antimicrob Agents Chemother 68:e0166923.
    doi: 10.1128/aac.01669-23pmc: PMC11064530pubmed: 38564665google scholar: lookup
  244. Abraham S, Wong HS, Turnidge J, Johnson JR, Trott DJ. Carbapenemase-producing bacteria in companion animals: a public health concern on the horizon.. J Antimicrob Chemother 69:1155–1157.
    doi: 10.1093/jac/dkt518pubmed: 24398342google scholar: lookup
  245. UK-VARSS. Veterinary antibiotic resistance and sales surveillance report.. 2020.
  246. Yan L, Sun J, Xu X, Huang S. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.. Antimicrob Resist Infect Control 9:155.
    doi: 10.1186/s13756-020-00816-4pmc: PMC7513325pubmed: 32967718google scholar: lookup
  247. Shen Z, Hu Y, Sun Q, Hu F, Zhou H, Shu L, Ma T, Shen Y, Wang Y, Li J, Walsh TR, Zhang R, Wang S. Emerging Carriage of NDM-5 and MCR-1 in Escherichia coli from healthy people in multiple regions in China: a cross sectional observational study.. EClinMed 6:11–20.
  248. Goggs R, Menard JM, Altier C, Cummings KJ, Jacob ME, Lalonde-Paul DF, Papich MG, Norman KN, Fajt VR, Scott HM, Lawhon SD. Patterns of antimicrobial drug use in veterinary primary care and specialty practice: a 6-year multi-institution study.. J Vet Intern Med 35:1496–1508.
    doi: 10.1111/jvim.16136pmc: PMC8163138pubmed: 33942943google scholar: lookup
  249. Smith A, Wayne AS, Fellman CL, Rosenbaum MH. Usage patterns of carbapenem antimicrobials in dogs and cats at a veterinary tertiary care hospital.. J Vet Intern Med 33:1677–1685.
    doi: 10.1111/jvim.15522pmc: PMC6639476pubmed: 31119803google scholar: lookup
  250. The AMR One Health Surveillance Committee. Nippon AMR one health report (NAOR). 2022.
  251. Knox J, Uhlemann AC, Lowy FD. Staphylococcus aureus infections: transmission within households and the community.. Trends Microbiol 23:437–444.
    doi: 10.1016/j.tim.2015.03.007pmc: PMC4490959pubmed: 25864883google scholar: lookup
  252. Madigan T, Johnson JR, Clabots C, Johnston BD, Porter SB, Slater BS, Banerjee R. Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-spectrum β-lactamase–producing Escherichia coli sequence type 131.. Clin Infect Dis 61:e5–e12.
    doi: 10.1093/cid/civ273pmc: PMC4542914pubmed: 25828998google scholar: lookup
  253. Mollema FPN, Richardus JH, Behrendt M, Vaessen N, Lodder W, Hendriks W, Verbrugh HA, Vos MC. Transmission of methicillin-resistant Staphylococcus aureus to household contacts.. J Clin Microbiol 48:202–207.
    doi: 10.1128/JCM.01499-09pmc: PMC2812253pubmed: 19923490google scholar: lookup
  254. FDA Center for Veterinary Medicine. Supporting antimicrobial stewardship in veterinary settings Goals for fiscal years 2024-2028: Key phase 3 and phase 4 actions. 2024.
  255. TATFAR. Reporting of sales and use of antimicrobials per animal species by TATFAR members. 2023.
  256. World Organisation for Animal Health. Annual report on antimicrobial agents intended for use in animals. 8th report. Paris. 2024.
  257. World Health Organization. WHO’s List of medically important antimicrobials: a risk management tool for mitigating antimicrobial resistance due to non-human use.. 2024.